Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Convertible Preferred Stock Series Seed convertible preferred stock	Convertible Preferred Stock Series A convertible preferred stock	Convertible Preferred Stock Series B convertible preferred stock	Convertible Preferred Stock Series C convertible preferred stock	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Series Seed convertible preferred stock	Series A convertible preferred stock	Series B convertible preferred stock	Total
Balance at the beginning at Dec. 31, 2022	$ 956	$ 55,840	$ 183,290
Balance at the beginning (in shares) at Dec. 31, 2022	1,785,714	17,589,380	77,052,632
Balance at the end at Mar. 31, 2023	$ 956	$ 55,840	$ 183,290
Balance at the end (in shares) at Mar. 31, 2023	1,785,714	17,589,380	77,052,632
Balance at the beginning at Dec. 31, 2022						$ 1,034	$ (41)	$ (193,279)				$ (192,286)
Balance at the beginning (in shares) at Dec. 31, 2022					1,549,275
Changes in Stockholders' Equity (Deficit)
Exercises of common stock options						55						55
Exercises of common stock options (in shares)					15,835
Stock-based compensation expense						687						687
Net (loss) income								(19,098)				(19,098)
Foreign currency translation adjustment							(4)					(4)
Balance at the end at Mar. 31, 2023						1,776	(45)	(212,377)				(210,646)
Balance at the end (in shares) at Mar. 31, 2023					1,565,110
Balance at the beginning at Dec. 31, 2022	$ 956	$ 55,840	$ 183,290
Balance at the beginning (in shares) at Dec. 31, 2022	1,785,714	17,589,380	77,052,632
Balance at the end at Sep. 30, 2023	$ 956	$ 55,840	$ 193,290
Balance at the end (in shares) at Sep. 30, 2023	1,785,714	17,589,380	81,242,587
Balance at the beginning at Dec. 31, 2022						1,034	(41)	(193,279)				(192,286)
Balance at the beginning (in shares) at Dec. 31, 2022					1,549,275
Changes in Stockholders' Equity (Deficit)
Net (loss) income												(12,537)
Foreign currency translation adjustment												165
Balance at the end at Sep. 30, 2023						3,460	124	(205,816)				(202,232)
Balance at the end (in shares) at Sep. 30, 2023					1,568,218
Balance at the beginning at Mar. 31, 2023	$ 956	$ 55,840	$ 183,290
Balance at the beginning (in shares) at Mar. 31, 2023	1,785,714	17,589,380	77,052,632
Changes in Convertible Preferred Stock
Issuance of convertible preferred stock			$ 10,000
Issuance of convertible preferred stock (in shares)			4,189,955
Balance at the end at Jun. 30, 2023	$ 956	$ 55,840	$ 193,290
Balance at the end (in shares) at Jun. 30, 2023	1,785,714	17,589,380	81,242,587
Balance at the beginning at Mar. 31, 2023						1,776	(45)	(212,377)				(210,646)
Balance at the beginning (in shares) at Mar. 31, 2023					1,565,110
Changes in Stockholders' Equity (Deficit)
Exercises of common stock options						11						11
Exercises of common stock options (in shares)					3,108
Stock-based compensation expense						669						669
Net (loss) income								(29,047)				(29,047)
Foreign currency translation adjustment							160					160
Balance at the end at Jun. 30, 2023						2,456	115	(241,424)				(238,853)
Balance at the end (in shares) at Jun. 30, 2023					1,568,218
Balance at the end at Sep. 30, 2023	$ 956	$ 55,840	$ 193,290
Balance at the end (in shares) at Sep. 30, 2023	1,785,714	17,589,380	81,242,587
Changes in Stockholders' Equity (Deficit)
Stock-based compensation expense						1,004						1,004
Net (loss) income								35,608				35,608
Foreign currency translation adjustment							9					9
Balance at the end at Sep. 30, 2023						3,460	124	(205,816)				(202,232)
Balance at the end (in shares) at Sep. 30, 2023					1,568,218
Balance at the beginning at Dec. 31, 2023	$ 956	$ 55,840	$ 193,290						$ 956	$ 55,840	$ 193,290	$ 250,086
Balance at the beginning (in shares) at Dec. 31, 2023	1,785,714	17,589,380	81,242,587						1,785,714	17,589,380	81,242,587	100,617,681
Balance at the end at Mar. 31, 2024	$ 956	$ 55,840	$ 193,290
Balance at the end (in shares) at Mar. 31, 2024	1,785,714	17,589,380	81,242,587
Balance at the beginning at Dec. 31, 2023						4,645	37	(230,403)				$ (225,721)
Balance at the beginning (in shares) at Dec. 31, 2023					1,576,854
Changes in Stockholders' Equity (Deficit)
Repurchase of unvested restricted stock awards (in shares)					(21,172)
Exercises of common stock options						42						42
Exercises of common stock options (in shares)					7,035
Stock-based compensation expense						947						947
Net (loss) income								(27,800)				(27,800)
Foreign currency translation adjustment							37					37
Balance at the end at Mar. 31, 2024						5,634	74	(258,203)				(252,495)
Balance at the end (in shares) at Mar. 31, 2024					1,562,717
Balance at the beginning at Dec. 31, 2023	$ 956	$ 55,840	$ 193,290						$ 956	$ 55,840	$ 193,290	$ 250,086
Balance at the beginning (in shares) at Dec. 31, 2023	1,785,714	17,589,380	81,242,587						1,785,714	17,589,380	81,242,587	100,617,681
Balance at the end (in shares) at Sep. 30, 2024									0	0	0
Balance at the beginning at Dec. 31, 2023						4,645	37	(230,403)				$ (225,721)
Balance at the beginning (in shares) at Dec. 31, 2023					1,576,854
Changes in Stockholders' Equity (Deficit)
Net (loss) income												(104,384)
Foreign currency translation adjustment												16
Balance at the end at Sep. 30, 2024					$ 4	694,163	54	(334,786)				359,435
Balance at the end (in shares) at Sep. 30, 2024					41,780,938
Balance at the beginning at Mar. 31, 2024	$ 956	$ 55,840	$ 193,290
Balance at the beginning (in shares) at Mar. 31, 2024	1,785,714	17,589,380	81,242,587
Changes in Convertible Preferred Stock
Issuance of convertible preferred stock				$ 199,526
Issuance of convertible preferred stock (in shares)				116,275,239
Balance at the end at Jun. 30, 2024	$ 956	$ 55,840	$ 193,290	$ 199,526
Balance at the end (in shares) at Jun. 30, 2024	1,785,714	17,589,380	81,242,587	116,275,239
Balance at the beginning at Mar. 31, 2024						5,634	74	(258,203)				(252,495)
Balance at the beginning (in shares) at Mar. 31, 2024					1,562,717
Changes in Stockholders' Equity (Deficit)
Exercises of common stock options						124						124
Exercises of common stock options (in shares)					15,655
Stock-based compensation expense						1,536						1,536
Net (loss) income								(37,977)				(37,977)
Foreign currency translation adjustment							30					30
Balance at the end at Jun. 30, 2024						7,294	104	(296,180)				(288,782)
Balance at the end (in shares) at Jun. 30, 2024					1,578,372
Changes in Convertible Preferred Stock
Conversion of convertible preferred stock to common stock upon closing of initial public offering	$ (956)	$ (55,840)	$ (193,290)	$ (199,526)
Conversion of convertible preferred stock to common stock upon closing of initial public offering (in shares)	(1,785,714)	(17,589,380)	(81,242,587)	(116,275,239)
Balance at the end (in shares) at Sep. 30, 2024									0	0	0
Changes in Stockholders' Equity (Deficit)
Exercises of common stock options						32						32
Exercises of common stock options (in shares)					3,263
Stock-based compensation expense						2,843						2,843
Net (loss) income								(38,606)				(38,606)
Foreign currency translation adjustment							(50)					(50)
Conversion of convertible preferred stock to common stock upon closing of initial public offering					$ 2	449,610						449,612
Conversion of convertible preferred stock to common stock upon closing of initial public offering (in shares)					24,978,715
Issuance of common stock					$ 2	234,384						234,386
Issuance of common stock (in shares)					15,220,588
Balance at the end at Sep. 30, 2024					$ 4	$ 694,163	$ 54	$ (334,786)				$ 359,435
Balance at the end (in shares) at Sep. 30, 2024					41,780,938